AbbVie Inc - Total Cash From Operating Activities

AbbVie Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Cash-From-Operating-Activities" stands at 20.86 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 06/30/2024.

AbbVie Inc's third quarter result of 7.02 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 36.31 percent compared to it's second quarter result.

Also, AbbVie Inc's third quarter result of 7.02 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 28.95 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), AbbVie Inc's third quarter result of 20.86 Billion USD for the item "Total Cash From Operating Activities" represents an increase of 8.18 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 26.34 percent compared to the value the year prior.
The 1 year change in percent is 26.34.
The 3 year change in percent is -7.66.
The 5 year change in percent is 30.30.
The 10 year change in percent is 317.70.

The Serie's long term average value is 13.12 Billion United States Dollars. It's latest available value, on 09/30/2025, is 58.95 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2014, to it's latest available value, on 09/30/2025, is +487.77%.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -18.33%.